+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ciclosporin"

Cyclosporine Drugs Market Report 2025 - Product Thumbnail Image

Cyclosporine Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Cyclosporine Market Report 2025 - Product Thumbnail Image

Cyclosporine Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Cyclosporine Injection Market - Global Forecast 2025-2030 - Product Thumbnail Image

Cyclosporine Injection Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 190 Pages
  • Global
From
From
Cyclosporine Eye Drop Market - Global Forecast 2025-2030 - Product Thumbnail Image

Cyclosporine Eye Drop Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
Ciclosporin Eye Drops Market - Global Forecast 2025-2030 - Product Thumbnail Image

Ciclosporin Eye Drops Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
Alopecia Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Alopecia Drugs Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 186 Pages
  • Global
From
From
From
Selective Immunosuppressants Market - Global Forecast 2025-2030 - Product Thumbnail Image

Selective Immunosuppressants Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 193 Pages
  • Global
From
Immunosuppressants Market Report 2025 - Product Thumbnail Image

Immunosuppressants Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Ocular Immunosuppressants Market - Global Forecast 2025-2030 - Product Thumbnail Image

Ocular Immunosuppressants Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
From
From
Adult-Onset Still Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Adult-Onset Still Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Chronic Spontaneous Urticaria - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Spontaneous Urticaria - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Graft Versus Host Disease (GvHD) - Pipeline Insight, 2025 - Product Thumbnail Image

Graft Versus Host Disease (GvHD) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Chronic Urticaria Or Hives - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Urticaria Or Hives - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator

Ciclosporin is an immunosuppressant drug used to treat a variety of immune disorders, including rheumatoid arthritis, psoriasis, and inflammatory bowel disease. It works by suppressing the body's immune system, which helps to reduce inflammation and prevent organ rejection in transplant patients. It is also used to treat certain types of eye inflammation. Ciclosporin is available in both oral and topical formulations. Ciclosporin is a widely used drug in the treatment of immune disorders, and is often prescribed in combination with other drugs. It is generally well tolerated, with few side effects. However, it can cause serious side effects, such as high blood pressure, kidney damage, and increased risk of infection. The ciclosporin market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Novartis, Pfizer, Merck, and Sanofi. Other companies include Mylan, Teva, and Sandoz. Show Less Read more